11.00
price down icon1.26%   -0.14
after-market Dopo l'orario di chiusura: 11.00
loading
Precedente Chiudi:
$11.14
Aprire:
$11.05
Volume 24 ore:
1.54M
Relative Volume:
1.49
Capitalizzazione di mercato:
$1.04B
Reddito:
$174.54M
Utile/perdita netta:
$6.03M
Rapporto P/E:
137.50
EPS:
0.08
Flusso di cassa netto:
$15.96M
1 W Prestazione:
-1.26%
1M Prestazione:
-3.25%
6M Prestazione:
+23.46%
1 anno Prestazione:
+18.03%
Intervallo 1D:
Value
$10.99
$11.11
Intervallo di 1 settimana:
Value
$10.99
$11.17
Portata 52W:
Value
$7.83
$11.80

Enfusion Inc Stock (ENFN) Company Profile

Name
Nome
Enfusion Inc
Name
Telefono
(312) 253-9800
Name
Indirizzo
125 SOUTH CLARK STREET, SUITE 750, CHICAGO
Name
Dipendente
1,143
Name
Cinguettio
Name
Prossima data di guadagno
2024-08-06
Name
Ultimi documenti SEC
Name
ENFN's Discussions on Twitter

Confronta ENFN con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Software - Application icon
ENFN
Enfusion Inc
11.00 1.04B 174.54M 6.03M 15.96M 0.08
Software - Application icon
SAP
Sap Se Adr
264.34 308.38B 36.97B 3.37B 4.79B 2.8498
Software - Application icon
CRM
Salesforce Inc
255.23 245.28B 37.90B 6.20B 12.43B 6.36
Software - Application icon
INTU
Intuit Inc
598.53 167.33B 17.17B 3.04B 5.63B 10.72
Software - Application icon
NOW
Servicenow Inc
774.07 159.84B 10.98B 1.43B 3.38B 6.83
Software - Application icon
ADBE
Adobe Inc
367.25 156.52B 22.04B 6.75B 9.19B 15.18

Enfusion Inc Stock (ENFN) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-05-10 Ripresa Morgan Stanley Overweight
2024-02-28 Downgrade Goldman Neutral → Sell
2024-01-30 Downgrade JP Morgan Neutral → Underweight
2023-11-07 Iniziato UBS Neutral
2023-04-03 Iniziato Piper Sandler Neutral
2023-03-15 Iniziato JP Morgan Neutral
2023-01-04 Downgrade BofA Securities Neutral → Underperform
2023-01-03 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2022-10-03 Downgrade BofA Securities Buy → Neutral
2021-11-15 Iniziato BofA Securities Buy
2021-11-15 Iniziato Credit Suisse Neutral
2021-11-15 Iniziato Goldman Neutral
2021-11-15 Iniziato Morgan Stanley Equal-Weight
2021-11-15 Iniziato Piper Sandler Overweight
2021-11-15 Iniziato Stifel Buy
2021-11-15 Iniziato William Blair Outperform
Mostra tutto

Enfusion Inc Borsa (ENFN) Ultime notizie

pulisher
Apr 02, 2025

Clearwater Analytics and Enfusion Announce Election Deadline for Enfusion Shareholders to Elect Form of Merger Consideration - 01net

Apr 02, 2025
pulisher
Apr 02, 2025

Critical Merger Deadline: Enfusion Shareholders Must Choose Payment Type by April 16 - Stock Titan

Apr 02, 2025
pulisher
Apr 02, 2025

ENFUSION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Enfusion, Inc.ENFN - Business Wire

Apr 02, 2025
pulisher
Mar 30, 2025

Learn to Evaluate (ENFN) using the Charts - news.stocktradersdaily.com

Mar 30, 2025
pulisher
Mar 27, 2025

Shareholder Rights Advocates at Levi & Korsinsky Investigate Enfusion, Inc. (ENFN) Regarding Possible Securities Fraud Violations - ACCESS Newswire

Mar 27, 2025
pulisher
Mar 26, 2025

Lost Money on Enfusion, Inc. (ENFN)? Contact Levi & Korsinsky Regarding an Ongoing Investigation - ACCESS Newswire

Mar 26, 2025
pulisher
Mar 24, 2025

Bank of New York Mellon Corp Increases Stock Holdings in Enfusion, Inc. (NYSE:ENFN) - Defense World

Mar 24, 2025
pulisher
Mar 20, 2025

MS cuts rating on Enfusion stock after Clearwater’s acquisition bid - MSN

Mar 20, 2025
pulisher
Mar 20, 2025

(ENFN) Trading Report - Stock Traders Daily

Mar 20, 2025
pulisher
Mar 09, 2025

Enfusion, Inc. Reports Strong Growth Amid Acquisition Plans - MSN

Mar 09, 2025
pulisher
Mar 09, 2025

Enfusion (ENFN) to Release Earnings on Tuesday - Defense World

Mar 09, 2025
pulisher
Mar 08, 2025

Enfusion CEO Oleg Movchan sells $130,472 in stock By Investing.com - Investing.com South Africa

Mar 08, 2025
pulisher
Mar 08, 2025

Rhumbline Advisers Has $643,000 Stake in Enfusion, Inc. (NYSE:ENFN) - Defense World

Mar 08, 2025
pulisher
Mar 08, 2025

Enfusion’s chief people officer sells shares worth $35,558 - Investing.com India

Mar 08, 2025
pulisher
Mar 08, 2025

Enfusion CFO sells $52,836 in stock to cover tax obligations By Investing.com - Investing.com Canada

Mar 08, 2025
pulisher
Mar 07, 2025

Enfusion Executives Cash In: Major Stock Sales Unveiled! - TipRanks

Mar 07, 2025
pulisher
Mar 07, 2025

Enfusion chief accounting officer sells $6,165 in stock By Investing.com - Investing.com Canada

Mar 07, 2025
pulisher
Mar 07, 2025

Enfusion’s general counsel Matthew Campobasso sells $19,280 in stock - Investing.com

Mar 07, 2025
pulisher
Mar 07, 2025

Enfusion chief accounting officer sells $6,165 in stock - Investing.com

Mar 07, 2025
pulisher
Mar 07, 2025

Enfusion COO Neal Pawar sells $165,620 in stock - Investing.com

Mar 07, 2025
pulisher
Mar 07, 2025

Enfusion’s chief people officer sells shares worth $35,558 By Investing.com - Investing.com South Africa

Mar 07, 2025
pulisher
Mar 07, 2025

Enfusion Executives Sell Shares to Cover Tax Obligations - TradingView

Mar 07, 2025
pulisher
Mar 07, 2025

Enfusion’s Hold Rating: Balancing Strategic Merger Benefits with Market Uncertainties - TipRanks

Mar 07, 2025
pulisher
Mar 07, 2025

Enfusion CEO Oleg Movchan sells $130,472 in stock - Investing.com

Mar 07, 2025
pulisher
Mar 06, 2025

Enfusion’s CAO Makes a Noteworthy Stock Sale! - TipRanks

Mar 06, 2025
pulisher
Mar 06, 2025

Enfusion’s general counsel sells $12,410 in stock to cover taxes By Investing.com - Investing.com South Africa

Mar 06, 2025
pulisher
Mar 06, 2025

Enfusion COO Neal Pawar sells $31,790 in stock - Investing.com India

Mar 06, 2025
pulisher
Mar 06, 2025

Enfusion Executives Unload Major Stock Holdings! - TipRanks

Mar 06, 2025
pulisher
Mar 05, 2025

Enfusion COO Neal Pawar sells $31,790 in stock By Investing.com - Investing.com Canada

Mar 05, 2025
pulisher
Mar 05, 2025

Enfusion chief accounting officer sells $2,514 in stock - Investing.com Australia

Mar 05, 2025
pulisher
Mar 05, 2025

Enfusion chief accounting officer sells $2,514 in stock By Investing.com - Investing.com South Africa

Mar 05, 2025
pulisher
Mar 05, 2025

Enfusion CEO Oleg Movchan sells $32,031 in stock By Investing.com - Investing.com Canada

Mar 05, 2025
pulisher
Mar 05, 2025

Enfusion CFO Bradley Herring sells $17,600 in stock By Investing.com - Investing.com South Africa

Mar 05, 2025
pulisher
Mar 05, 2025

Enfusion’s chief people officer sells shares worth $23,696 - Investing.com India

Mar 05, 2025
pulisher
Mar 05, 2025

Enfusion CEO Oleg Movchan sells $32,031 in stock - Investing.com

Mar 05, 2025
pulisher
Mar 05, 2025

Enfusion’s chief people officer sells shares worth $23,696 By Investing.com - Investing.com South Africa

Mar 05, 2025
pulisher
Mar 04, 2025

Stifel maintains Enfusion stock Hold rating, $11.25 target By Investing.com - Investing.com Canada

Mar 04, 2025
pulisher
Mar 04, 2025

Stifel maintains Enfusion stock Hold rating, $11.25 target - Investing.com India

Mar 04, 2025
pulisher
Mar 04, 2025

Enfusion, Inc. (ENFN) Lags Q4 Earnings and Revenue Estimates - MSN

Mar 04, 2025
pulisher
Mar 04, 2025

Enfusion earnings missed by $0.03, revenue fell short of estimates - Investing.com Canada

Mar 04, 2025
pulisher
Mar 03, 2025

Enfusion Q4 Adjusted Earnings Fall, Revenue Rises -March 03, 2025 at 05:38 pm EST - Marketscreener.com

Mar 03, 2025
pulisher
Mar 03, 2025

Enfusion Announces Fourth Quarter and Full Year 2024 Results - TradingView

Mar 03, 2025
pulisher
Mar 03, 2025

Earnings Flash (ENFN) ENFUSION INC. Reports Q4 Revenue $52.9M, vs. FactSet Est of $54.3M - Marketscreener.com

Mar 03, 2025

Enfusion Inc Azioni (ENFN) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
software_application APP
$261.98
price down icon 9.78%
$82.29
price down icon 18.24%
$165.17
price down icon 4.63%
software_application ADP
$305.39
price down icon 0.60%
$69.85
price down icon 6.24%
$367.25
price down icon 4.80%
Capitalizzazione:     |  Volume (24 ore):